Several other studies reported the role of tumor miRNAs in controlling the expression of other NKG2D ligands, including MHC class I polypeptide-related sequence B (MICB), UL16 binding protein (ULBP), and other immunological mediators (213, 282, 283). The gene discussed is MICB; the disease is neoplasm.